Administration of nonanticoagulant heparin inhibits the loss of glycosaminoglycans from xenogeneic cardiac grafts and prolongs graft survival.

R. Brian Stevens, Y L Wang, H Kaji, J Lloveras, Agustin P. Dalmasso, Fritz H. Bach, Pablo Rubinstein, D. E. R. Sutherland, Jeffrey L. Platt

PubMed · 1993 · 31 citations · 0 references

Full text

Open access

Concepts